Question Does technology-assisted buprenorphine (TAB) treatment delivered over 24 weeks reduce illicit opioid use among individuals residing in nonrural (trial 1) and rural (trial 2) communities?
Objective To evaluate technology-assisted buprenorphine (TAB) efficacy (1) over a longer period than previously examined, (2) with the addition of overdose education, and (3) among individuals residing in rural communities.
Article continues at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2809950